HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin.
Phagocytosis of apoptotic cells is critical to resolution of inflammation. High mobility group box 1 protein (HMGB1), a mediator of inflammation, has been shown to diminish phagocytosis through binding to phosphatidylserine (PS) exposed on the surface of apoptotic neutrophils. However, it is currently unknown whether HMGB1 also modulates the activity of receptors involved in PS recognition on the surface of phagocytes. In the present studies, we found that preincubation of macrophages with HMGB1 decreased their ability to engulf apoptotic neutrophils or thymocytes. Preincubation of macrophages with HMGB1 prevented the enhancement of efferocytosis resulting from exposure to milk fat globule EGF factor 8 (MFG-E8), an opsonin that bridges PS and α(v)β(3) as well as α(v)β(5)-integrins on the surface of phagocytes. The inhibitory effect of HMGB1 on the phagocytic activity of macrophages was prevented by preincubation of HMGB1 with soluble α(v)β(3), but not with soluble α(v)β(5). HMGB1 colocalized with the β(3)-integrin on the cell membrane of macrophages and bound to soluble α(v)β(3), but not to soluble α(v)β(5). HMGB1 suppressed the interaction between MFG-E8 and α(v)β(3). HMGB1 also inhibited intracellular signaling events, including ERK phosphorylation and Rac-1 activation, which are activated in macrophages during phagocytosis of apoptotic cells. These results demonstrate that HMGB1 blocks α(v)β(3)-dependent recognition and uptake of apoptotic cells.
Friggeri
Arnaud
A
Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
Yang
Yanping
Y
Banerjee
Sami
S
Park
Yong-Jun
YJ
Liu
Gang
G
Abraham
Edward
E
D000818:Animals; D000954:Antigens, Surface / Q000378:metabolism; D017209:Apoptosis; D057809:HEK293 Cells; D024243:HMGB1 Protein / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000378:metabolism*; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000502:physiology*; D008297:Male; D051379:Mice; D008894:Milk Proteins / Q000378:metabolism; D009504:Neutrophils / Q000502:physiology; D010587:Phagocytosis; D010718:Phosphatidylserines / Q000378:metabolism; D019030:Receptors, Vitronectin / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology
D000954:Antigens, Surface; D024243:HMGB1 Protein; D039302:Integrin alphaVbeta3; C490919:Mfge8 protein, mouse; D008894:Milk Proteins; D010718:Phosphatidylserines; D019030:Receptors, Vitronectin; D011994:Recombinant Proteins; C064660:integrin alphaVbeta5
Nature. 2002 May 9;417(6885):182-7
12000961
Arthritis Rheum. 2003 Apr;48(4):876-81
12687528
J Leukoc Biol. 2007 Jan;81(1):49-58
16980512
Lupus. 1997;6(9):701-7
9412984
Am J Physiol Lung Cell Mol Physiol. 2008 Apr;294(4):L601-11
18178675
Am J Respir Crit Care Med. 2010 Feb 1;181(3):238-46
19892861
J Immunol. 2007 Nov 15;179(10):7079-86
17982099
Am J Physiol Lung Cell Mol Physiol. 2005 May;288(5):L958-65
15640285
J Biol Chem. 2002 Mar 1;277(9):7021-8
11748221
J Immunol. 2000 Sep 15;165(6):2950-4
10975801
Cell. 2003 Jun 27;113(7):817-20
12837239
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11784-9
18689689
J Leukoc Biol. 2009 Sep;86(3):609-15
19414537
Cell Death Differ. 2008 Feb;15(2):243-50
17571081
Science. 2004 May 21;304(5674):1147-50
15155946
J Immunol. 2009 Jun 1;182(11):7222-32
19454719
Exp Cell Res. 2004 Jan 15;292(2):403-16
14697347
J Clin Invest. 1998 Feb 15;101(4):890-8
9466984
J Cell Biol. 2001 Nov 12;155(4):649-59
11706053
J Cell Biol. 2001 Mar 19;152(6):1197-206
11257120
Arthritis Rheum. 1998 Jul;41(7):1241-50
9663482
Curr Dir Autoimmun. 2006;9:162-72
16394660
Am J Physiol Cell Physiol. 2003 Apr;284(4):C870-9
12620891
J Cell Sci. 2007 Jul 1;120(Pt 13):2143-9
17591687
Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S5-11
10556161
Chest. 2006 Jun;129(6):1673-82
16778289
Trends Cell Biol. 2006 Apr;16(4):189-97
16529932
Am J Respir Crit Care Med. 2008 Oct 15;178(8):822-31
18658107
Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L677-86
19633071
J Leukoc Biol. 2009 Nov;86(5):1089-95
19414539
J Leukoc Biol. 2009 Sep;86(3):573-6
19414536
Am J Respir Cell Mol Biol. 1995 Feb;12(2):232-7
7865221
Lung. 1998;176(2):89-98
9500294
Nat Immunol. 2007 May;8(5):487-96
17417641
J Immunol. 2008 Feb 15;180(4):2531-7
18250463
J Immunol. 2009 Nov 15;183(10):6244-50
19890065
J Clin Invest. 1992 Oct;90(4):1513-22
1383273
Nat Rev Immunol. 2007 Dec;7(12):964-74
18037898
Nature. 1990 Jan 11;343(6254):170-3
1688647
EMBO J. 2007 Feb 21;26(4):1129-39
17268551
Arthritis Rheum. 2002 Jan;46(1):191-201
11817590
J Cell Sci. 2008 Jun 1;121(11):1773-83
18492791
J Immunol. 2008 Sep 15;181(6):4240-6
18768881
Crit Care Med. 2007 Apr;35(4):1061-7
17334246